Ad
Wednesday, 7 March 2018
Europe's medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug
(Reuters) - Europe's medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc's multiple sclerosis drug Zinbryta, following 12 reports of inflammation of the brain, three of which cases were fatal.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment